Olectra Greentech Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 13, 2025, 5:47 am

Competitors of Olectra Greentech Ltd

All Competitor Stocks of Olectra Greentech Ltd

Quarterly Result

Last Updated: May 31, 2025, 8:15 am

Below is a detailed analysis of the quarterly data for Olectra Greentech Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 449.00 Cr.. The value appears to be declining and may need further review. It has decreased from 515.00 Cr. (Dec 2024) to 449.00 Cr., marking a decrease of 66.00 Cr..
• For Expenses, as of Mar 2025, the value is 395.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 436.00 Cr. (Dec 2024) to 395.00 Cr., marking a decrease of 41.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 54.00 Cr.. The value appears to be declining and may need further review. It has decreased from 79.00 Cr. (Dec 2024) to 54.00 Cr., marking a decrease of 25.00 Cr..
• For OPM %, as of Mar 2025, the value is 12.00%. The value appears to be declining and may need further review. It has decreased from 15.00% (Dec 2024) to 12.00%, marking a decrease of 3.00%.
• For Other Income, as of Mar 2025, the value is 5.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Dec 2024) to 5.00 Cr., marking an increase of 2.00 Cr..
• For Interest, as of Mar 2025, the value is 20.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11.00 Cr. (Dec 2024) to 20.00 Cr., marking an increase of 9.00 Cr..
• For Depreciation, as of Mar 2025, the value is 10.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9.00 Cr. (Dec 2024) to 10.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 29.00 Cr.. The value appears to be declining and may need further review. It has decreased from 62.00 Cr. (Dec 2024) to 29.00 Cr., marking a decrease of 33.00 Cr..
• For Tax %, as of Mar 2025, the value is 29.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Dec 2024) to 29.00%, marking an increase of 4.00%.
• For Net Profit, as of Mar 2025, the value is 21.00 Cr.. The value appears to be declining and may need further review. It has decreased from 47.00 Cr. (Dec 2024) to 21.00 Cr., marking a decrease of 26.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 2.56. The value appears to be declining and may need further review. It has decreased from 5.64 (Dec 2024) to 2.56, marking a decrease of 3.08.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: Unknown

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 12, 2025, 2:58 pm

Below is a detailed analysis of the balance sheet data for Olectra Greentech Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 33.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 33.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,016.00 Cr.. The value appears strong and on an upward trend. It has increased from 881.00 Cr. (Mar 2024) to 1,016.00 Cr., marking an increase of 135.00 Cr..
• For Borrowings, as of Mar 2025, the value is 255.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 121.00 Cr. (Mar 2024) to 255.00 Cr., marking an increase of 134.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 867.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 554.00 Cr. (Mar 2024) to 867.00 Cr., marking an increase of 313.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,171.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,589.00 Cr. (Mar 2024) to 2,171.00 Cr., marking an increase of 582.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 355.00 Cr.. The value appears strong and on an upward trend. It has increased from 330.00 Cr. (Mar 2024) to 355.00 Cr., marking an increase of 25.00 Cr..
• For CWIP, as of Mar 2025, the value is 187.00 Cr.. The value appears strong and on an upward trend. It has increased from 72.00 Cr. (Mar 2024) to 187.00 Cr., marking an increase of 115.00 Cr..
• For Investments, as of Mar 2025, the value is 73.00 Cr.. The value appears strong and on an upward trend. It has increased from 11.00 Cr. (Mar 2024) to 73.00 Cr., marking an increase of 62.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,557.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,175.00 Cr. (Mar 2024) to 1,557.00 Cr., marking an increase of 382.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,171.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,589.00 Cr. (Mar 2024) to 2,171.00 Cr., marking an increase of 582.00 Cr..

Notably, the Reserves (1,016.00 Cr.) exceed the Borrowings (255.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Olectra Greentech Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 4.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 4.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 9.36. This value is within the healthy range. It has increased from 7.99 (Mar 23) to 9.36, marking an increase of 1.37.
• For Diluted EPS (Rs.), as of Mar 24, the value is 9.36. This value is within the healthy range. It has increased from 7.99 (Mar 23) to 9.36, marking an increase of 1.37.
• For Cash EPS (Rs.), as of Mar 24, the value is 13.08. This value is within the healthy range. It has increased from 11.86 (Mar 23) to 13.08, marking an increase of 1.22.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 111.67. It has increased from 102.47 (Mar 23) to 111.67, marking an increase of 9.20.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 111.67. It has increased from 102.47 (Mar 23) to 111.67, marking an increase of 9.20.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 140.61. It has increased from 132.89 (Mar 23) to 140.61, marking an increase of 7.72.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 21.63. This value is within the healthy range. It has increased from 18.44 (Mar 23) to 21.63, marking an increase of 3.19.
• For PBIT / Share (Rs.), as of Mar 24, the value is 17.16. This value is within the healthy range. It has increased from 14.40 (Mar 23) to 17.16, marking an increase of 2.76.
• For PBT / Share (Rs.), as of Mar 24, the value is 11.91. This value is within the healthy range. It has increased from 10.57 (Mar 23) to 11.91, marking an increase of 1.34.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 8.61. This value is within the healthy range. It has increased from 7.83 (Mar 23) to 8.61, marking an increase of 0.78.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 9.36. This value is within the healthy range. It has increased from 7.99 (Mar 23) to 9.36, marking an increase of 1.37.
• For PBDIT Margin (%), as of Mar 24, the value is 15.38. This value is within the healthy range. It has increased from 13.87 (Mar 23) to 15.38, marking an increase of 1.51.
• For PBIT Margin (%), as of Mar 24, the value is 12.20. This value is within the healthy range. It has increased from 10.83 (Mar 23) to 12.20, marking an increase of 1.37.
• For PBT Margin (%), as of Mar 24, the value is 8.47. This value is below the healthy minimum of 10. It has increased from 7.95 (Mar 23) to 8.47, marking an increase of 0.52.
• For Net Profit Margin (%), as of Mar 24, the value is 6.12. This value is within the healthy range. It has increased from 5.89 (Mar 23) to 6.12, marking an increase of 0.23.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 6.65. This value is below the healthy minimum of 8. It has increased from 6.01 (Mar 23) to 6.65, marking an increase of 0.64.
• For Return on Networth / Equity (%), as of Mar 24, the value is 8.41. This value is below the healthy minimum of 15. It has increased from 7.81 (Mar 23) to 8.41, marking an increase of 0.60.
• For Return on Capital Employeed (%), as of Mar 24, the value is 14.44. This value is within the healthy range. It has increased from 13.25 (Mar 23) to 14.44, marking an increase of 1.19.
• For Return On Assets (%), as of Mar 24, the value is 4.83. This value is below the healthy minimum of 5. It has increased from 4.21 (Mar 23) to 4.83, marking an increase of 0.62.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.01.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.13. This value is within the healthy range. It has decreased from 0.15 (Mar 23) to 0.13, marking a decrease of 0.02.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.73. It has decreased from 0.84 (Mar 23) to 0.73, marking a decrease of 0.11.
• For Current Ratio (X), as of Mar 24, the value is 1.88. This value is within the healthy range. It has increased from 1.72 (Mar 23) to 1.88, marking an increase of 0.16.
• For Quick Ratio (X), as of Mar 24, the value is 1.53. This value is within the healthy range. It has increased from 1.51 (Mar 23) to 1.53, marking an increase of 0.02.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 4.77. This value is within the healthy range. It has decreased from 9.01 (Mar 23) to 4.77, marking a decrease of 4.24.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 4.27. This value is below the healthy minimum of 20. It has decreased from 5.00 (Mar 23) to 4.27, marking a decrease of 0.73.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 2.89. This value is below the healthy minimum of 20. It has decreased from 3.32 (Mar 23) to 2.89, marking a decrease of 0.43.
• For Earning Retention Ratio (%), as of Mar 24, the value is 95.73. This value exceeds the healthy maximum of 70. It has increased from 95.00 (Mar 23) to 95.73, marking an increase of 0.73.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 97.11. This value exceeds the healthy maximum of 70. It has increased from 96.68 (Mar 23) to 97.11, marking an increase of 0.43.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 4.12. This value is within the healthy range. It has decreased from 4.82 (Mar 23) to 4.12, marking a decrease of 0.70.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 2.64. This value is below the healthy minimum of 3. It has decreased from 3.04 (Mar 23) to 2.64, marking a decrease of 0.40.
• For Enterprise Value (Cr.), as of Mar 24, the value is 15,452.34. It has increased from 5,044.07 (Mar 23) to 15,452.34, marking an increase of 10,408.27.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 13.39. This value exceeds the healthy maximum of 3. It has increased from 4.62 (Mar 23) to 13.39, marking an increase of 8.77.
• For EV / EBITDA (X), as of Mar 24, the value is 87.05. This value exceeds the healthy maximum of 15. It has increased from 33.33 (Mar 23) to 87.05, marking an increase of 53.72.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 13.43. This value exceeds the healthy maximum of 3. It has increased from 4.65 (Mar 23) to 13.43, marking an increase of 8.78.
• For Retention Ratios (%), as of Mar 24, the value is 95.72. This value exceeds the healthy maximum of 70. It has increased from 94.99 (Mar 23) to 95.72, marking an increase of 0.73.
• For Price / BV (X), as of Mar 24, the value is 16.97. This value exceeds the healthy maximum of 3. It has increased from 6.04 (Mar 23) to 16.97, marking an increase of 10.93.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 13.43. This value exceeds the healthy maximum of 3. It has increased from 4.65 (Mar 23) to 13.43, marking an increase of 8.78.
• For EarningsYield, as of Mar 24, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 23) to 0.00, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness